Stephens Inc. AR Has $761,000 Stock Holdings in Corteva, Inc. $CTVA

Stephens Inc. AR lessened its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 4.3% in the second quarter, according to its most recent filing with the SEC. The firm owned 10,206 shares of the company’s stock after selling 455 shares during the period. Stephens Inc. AR’s holdings in Corteva were worth $761,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of CTVA. Nuveen LLC acquired a new stake in Corteva during the 1st quarter worth $640,333,000. WCM Investment Management LLC grew its holdings in Corteva by 29.6% during the 2nd quarter. WCM Investment Management LLC now owns 9,044,706 shares of the company’s stock worth $672,836,000 after acquiring an additional 2,066,519 shares during the period. Assenagon Asset Management S.A. boosted its position in shares of Corteva by 4,769.2% during the second quarter. Assenagon Asset Management S.A. now owns 1,924,419 shares of the company’s stock worth $143,427,000 after purchasing an additional 1,884,897 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of Corteva by 54.6% during the first quarter. JPMorgan Chase & Co. now owns 5,009,038 shares of the company’s stock worth $315,219,000 after purchasing an additional 1,769,355 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its position in shares of Corteva by 65.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,251,449 shares of the company’s stock worth $204,615,000 after purchasing an additional 1,290,009 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the stock. Royal Bank Of Canada reduced their price target on shares of Corteva from $86.00 to $80.00 and set an “outperform” rating on the stock in a research report on Friday, October 17th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Corteva from $83.00 to $90.00 and gave the stock a “buy” rating in a research report on Monday, September 15th. Mizuho reduced their price target on shares of Corteva from $85.00 to $78.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 8th. UBS Group reduced their price target on shares of Corteva from $91.00 to $85.00 and set a “buy” rating on the stock in a research report on Monday, October 6th. Finally, Argus cut their price objective on shares of Corteva from $83.00 to $80.00 and set a “buy” rating on the stock in a research report on Monday, October 13th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $79.94.

Insider Buying and Selling at Corteva

In other news, EVP Robert D. King sold 37,280 shares of the business’s stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $74.20, for a total transaction of $2,766,176.00. Following the transaction, the executive vice president directly owned 49,262 shares in the company, valued at $3,655,240.40. The trade was a 43.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.14% of the stock is owned by corporate insiders.

Corteva Trading Up 0.2%

Shares of NYSE:CTVA opened at $63.63 on Friday. The company’s 50-day moving average price is $68.53 and its two-hundred day moving average price is $69.04. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.68 and a quick ratio of 1.23. Corteva, Inc. has a one year low of $53.40 and a one year high of $77.41. The stock has a market capitalization of $43.21 billion, a PE ratio of 31.04, a price-to-earnings-growth ratio of 1.45 and a beta of 0.76.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $2.20 EPS for the quarter, topping the consensus estimate of $1.89 by $0.31. Corteva had a net margin of 8.16% and a return on equity of 8.68%. The firm had revenue of $6.46 billion for the quarter, compared to analysts’ expectations of $6.26 billion. During the same period in the previous year, the firm posted $1.83 EPS. The company’s revenue for the quarter was up 5.6% on a year-over-year basis. On average, equities analysts forecast that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 15th. Stockholders of record on Tuesday, September 2nd were paid a dividend of $0.18 per share. The ex-dividend date was Tuesday, September 2nd. This represents a $0.72 annualized dividend and a dividend yield of 1.1%. This is a boost from Corteva’s previous quarterly dividend of $0.17. Corteva’s dividend payout ratio (DPR) is presently 35.12%.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.